TY - CHAP M1 - Book, Section TI - Goodman & Gilman Year in Review New and Noteworthy FDA Approvals A1 - Murri, PharmD, MBA, Nelda A2 - Brunton, Laurence L. A2 - Hilal-Dandan, Randa A2 - Knollmann, Björn C. Y1 - 2017 N1 - T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e AB - In 2017 the U.S. Food and Drug Administration (FDA) approved 40 noteworthy new drug products and granted 48 noteworthy new biologic licenses. Among the 40 new drug products are: SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - hemonc.mhmedical.com/content.aspx?aid=1164576137 ER -